Advertisement
Screener

Allarity Therapeutics, Inc. (ALLR) Operating Lease Right-of-Use Assets

2.8 / 5 stars · 68/120 Roast Me

Allarity Therapeutics, Inc. Operating Lease Right-of-Use Assets

Allarity Therapeutics, Inc. (ALLR) had Operating Lease Right-of-Use Assets of $6.00 thousand as of 2022-12-31, per its 10-K filed 2024-03-08.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OperatingLeaseRightOfUseAsset · last filed 2024-03-08

  • 2022-12-31: Operating Lease, Right-of-Use Asset $6.00K.
  • 2022-09-30: Operating Lease, Right-of-Use Asset $41.00K.
  • 2021-12-31: Operating Lease, Right-of-Use Asset $86.00K.
Period endOperating Lease, Right-of-Use Asset
2022-12-31$6.00K
10-K · filed 2024-03-08
2022-09-30$41.00K
10-Q · filed 2022-11-14
2021-12-31$86.00K
10-Q · filed 2022-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Lipocine Inc. (LPCN)United States$0.017B-1.79
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B